文献速递牙周病

利拉鲁肽调控牙周炎骨破坏并发挥抗炎作用

Liraglutide regulates bone destruction and exhibits anti-inflammatory effects in periodontitis in vitro and in vivo.
PubMed 文献 · J Dent · 2020-02-28

本研究探讨利拉鲁肽对Pg-LPS刺激的人牙周膜细胞成骨分化的影响及机制,并建立Wistar大鼠牙周炎模型评估其体内抗炎与骨保护作用。结果显示利拉鲁肽促进矿化结节形成和ALP、Runx2表达,逆转Pg-LPS对Wnt/β-catenin通路的激活及成骨抑制,体内减少炎性细胞浸润、降低TNF-α、IL-1β、IL-6浓度并减少牙槽骨吸收。

要点

  • 利拉鲁肽促进Pg-LPS刺激下hPDLCs成骨分化并上调ALP、Runx2表达
  • 利拉鲁肽可逆转Pg-LPS对Wnt/β-catenin通路的激活及成骨抑制
  • 全身给予利拉鲁肽可减轻大鼠牙周炎炎症与牙槽骨吸收

核心结论

  • 全身给予利拉鲁肽溶液是减轻牙周病炎症和骨丢失的潜在治疗方法,提示其可作为治疗牙周炎的潜在药物。

研究设计与样本

  • 体外研究检测利拉鲁肽对Pg-LPS刺激的hPDLCs成骨分化的影响及Wnt/β-catenin信号相关蛋白。
  • 体内建立雄性Wistar大鼠牙周炎模型,评估利拉鲁肽的抗炎与骨保护作用。

主要发现

  • 利拉鲁肽处理后矿化结节形成增加,ALP和Runx2表达上调。
  • Pg-LPS强烈激活Wnt/β-catenin信号通路并降低hPDLCs成骨,利拉鲁肽可逆转这些效应。
  • 体内利拉鲁肽减少牙周组织炎性细胞浸润,降低TNF-α、IL-1β、IL-6浓度,并减少牙槽骨吸收。

临床怎么用

  • 利拉鲁肽全身给药可能作为牙周炎辅助治疗药物,用于减轻炎症和牙槽骨丢失。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: This study investigated the effect of Liraglutide (LIRA) on osteogenic differentiation of human periodontal ligament cells (hPDLCs) stimulated by Porphyromonas gingivalis lipopolysaccharide (Pg-LPS) and its mechanismin in vitro. Further, investigated the osteoprotective and anti-inflammatory effects of LIRA in periodontitis in vivo. MATERIALS AND METHODS: ALP staining, Alizarin red staining(AR-S), qRT-PCR, Western Blot, and immunofluorescence staining were used to elucidate the effect of LIRA on osteogenesis of hPDLCs. Western Blot was performed to evaluate the Wnt/β-catenin signaling-related protein. Moreover, male Wistar rats model of periodontitis were established to assess the anti-inflammatory and osteoprotective effect of LIRA in vivo. RESULTS: After LIRA treatment, the formation of mineralized nodules was increased, the expression of ALP and Runx2 were upregulated. Moreover, Pg-LPS strongly activated the Wnt/β-catenin signaling pathway and reduced the osteogenesis of hPDLCs. But these effects were reversed by LIRA. The in vivo results showed that treatment with LIRA resulted in reduced inflammatory cell infiltration in periodontal tissues and decreased concentrations of TNF-α, IL-1β, and IL-6, and it reduced alveolar bone resorption. CONCLUSIONS: Systemic administration of LIRA solution is a potential treatment for reducing inflammation and bone loss in periodontal disease. This suggests that LIRA can be used as a potential drug for the treatment of periodontitis. CLINICAL SIGNIFICANCE: We showed that systemic administration of LIRA can have a beneficial effect in periodontitis. It can be used as a potential drug for the treatment of periodontitis.

来源:J Dent,查看原文。版权归原作者所有。

引用

  1. Zhang Y, Yuan X, Wu Y, et al. Liraglutide regulates bone destruction and exhibits anti-inflammatory effects in periodontitis in vitro and in vivo. J Dent. 2020. PMID: 32119967. doi:10.1016/j.jdent.2020.103310

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。